United States · FDA National Drug Code directory
Hydralazine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71610-562_547e8073-67bc-4f54-bcc9-0fb525db6687
- Product NDC
- 71610-562
- Form
- TABLET
- Composition / generic term
- Hydralazine Hydrochloride
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210304
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDRALAZINE HYDROCHLORIDE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 90 TABLET in 1 BOTTLE (71610-562-60) · 71610-562-60
- 180 TABLET in 1 BOTTLE (71610-562-80) · 71610-562-80
- 270 TABLET in 1 BOTTLE (71610-562-92) · 71610-562-92
- 540 TABLET in 1 BOTTLE (71610-562-98) · 71610-562-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →